CIS/Index
Copyright © 1999, Congressional Information
Service, Inc.
2000 CIS H 401106
TITLE: What Is
the U.S. Role in Combating the Global HIV/AIDS Epidemic
CIS-NO: 2000-H401-106
SOURCE: Committee on Government Reform.
House
DOC-TYPE: Hearing Retrieve
the full text of testimony
DATE: July 22, 1999
LENGTH:
iv+279 p.
CONG-SESS: 106-1
ITEM-NO: 1016-A; 1016-B
SUDOC: Y4.G74/7:G51
CIS DOCUMENT ON DEMAND: 1-800-227-2477 (Full
Text Reproductions)
INCLUDED IN LEGISLATIVE HISTORY OF: P.L.
106-264
SUMMARY:
Committee Serial No. 106-126.
Hearing before the Subcom on Criminal Justice, Drug Policy, and Human Resources
to examine HIV/AIDS epidemic in sub-Saharan African countries,
including the Republic of South Africa, and to review U.S. role
in combating the spread of AIDs in developing countries.
Supplementary material (p. 219, 221-231, 233-279) includes
submitted statements, witnesses' written replies to Subcom questions, and:
-- Pecoul, Bernard (et al., Fondation Medecins Sans
Frontieres), "Access to Essential Drugs in Poor Countries: A Lost Battle?"
Journal of the American Medical Association, Jan. 27, 1999 (p. 225-231).
CONTENT-NOTATION: AIDS epidemic in
Africa, review and US response
DESCRIPTORS:
ACQUIRED
IMMUNE DEFICIENCY SYNDROME; EPIDEMIOLOGY; FEDERAL AID TO
MEDICINE; INTERNATIONAL COOPERATION IN MEDICINE; TRADE REGULATION; DRUGS;
REPUBLIC OF SOUTH AFRICA; DEVELOPING COUNTRIES
00-H401-106 TESTIMONY NO: 1 July 22, 1999 p. 22-91
WITNESSES (and witness notations):
JACKSON,
JESSE L., JR. (Rep, D-Ill)
BERRY, MARION (Rep, D-Ark)
NKHOMA, CHATINKHA C. (Malawi citizen with
AIDS)
STATEMENTS AND DISCUSSION:
Overview of HIV/AIDS epidemic in
sub-Saharan Africa (related materials, p. 30-70); need for U.S.
to ensure Africa access to affordable AIDS
medicines.
CONTENT NOTATION:
AIDS epidemic in Africa,
review and US response
00-H401-106 TESTIMONY NO: 2
July 22, 1999 p. 92-139, 238-257
WITNESSES
(and witness notations):
THURMAN, SANDRA L. (Director,
Office of National AIDS Policy)
PAPOVICH,
JOSEPH (Assistant U.S. Trade Representative, Services, Investment and
Intellectual Property)
KILLEN, JOHN Y.
(Dr.) (Director, Division of AIDS, National Institute of
Allergy and Infectious Diseases, NIH)
DONDERO, TIMOTHY
(Dr.) (Chief, International Activities Branch, Division of
HIV/AIDS Prevention, CDC)
STATEMENTS AND
DISCUSSION:
Scope of HIV/AIDS epidemic in
sub-Saharan Africa; description of U.S. initiatives in
combating global HIV/AIDS epidemic; role of trade policy in
addressing Africa health concerns; perspectives on
HIV/AIDS treatment and prevention strategies.
CONTENT NOTATION:
AIDS epidemic in
Africa, review and US response
TESTIMONY
DESCRIPTORS:
OFFICE OF NATIONAL AIDS
POLICY; PREVENTIVE MEDICINE; OFFICE OF THE U.S. TRADE REPRESENTATIVE; NATIONAL
INSTITUTES OF HEALTH; CENTERS FOR DISEASE CONTROL AND PREVENTION
00-H401-106 TESTIMONY NO: 3 July 22, 1999 p.
139-218, 258-270
WITNESSES (and witness notations):
HERMAN, ALLEN A. (Dean, National School of Public Health,
Medical University of Southern Africa)
LOVE, JAMES P. (Director, Consumer Project on Technology)
LURIE, PETER (Dr.) (Medical Director, Public Citizen
Health Research Group)
SAWYER, ERIC (Director,
HIV/AIDS Human Rights Project)
SIEGFRIED,
JOHN (Dr.) (Senior Medical Officer, Pharmaceutical Research and Manufacturers of
America)
STATEMENTS AND DISCUSSION:
Overview of HIV/AIDS pandemic in Republic
of South Africa; views on U.S. trade policies impacting
HIV/AIDS epidemic in Africa and elsewhere
(related materials, p. 158-173); importance of policies to expand access to
HIV/AIDS drugs in Africa; description of
pharmaceutical industry efforts to combat HIV/AIDS epidemic.
CONTENT NOTATION:
AIDS
epidemic in Africa, review and US response
TESTIMONY DESCRIPTORS:
CONSUMER PROJECT ON TECHNOLOGY;
PHARMACEUTICAL INDUSTRY
LOAD-DATE: July 6, 2001
